Perception Neuroscience Initiates Phase 2a Study of PCN-101 (R-ketamine) for Treatment Resistant Depression pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
-Successfully completed Initial Public Offering on Nasdaq raising $258.8 million in gross proceeds, including the underwriters’ over-allotment- -Received.
atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update teletrader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from teletrader.com Daily Mail and Mail on Sunday newspapers.
Atai launches InnarisBio to target drug delivery for mental health epmmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from epmmagazine.com Daily Mail and Mail on Sunday newspapers.